In vitro Activities of Erythromycin, Tetracycline and Levofloxacin Alone and in Dual Combinations against Ureaplasma spp.

被引:3
作者
Luo, Di-Qing [1 ]
Liu, Jing-Ye [1 ]
Yang, Wei [2 ]
Zhang, Bin [1 ]
Yu, Min-Jun [3 ]
Wu, Yi-Mou [3 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Huangpu Hosp, Dept Dermatol, Guangzhou 510700, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Huangpu Hosp, Dept Pharm, Guangzhou 510700, Guangdong, Peoples R China
[3] Nanhua Univ, Coll Med, Pathogenic Biol Inst, Hengyang, Peoples R China
关键词
Antimicrobial agents; Erythromycin; Tetracycline; Levofloxacin; Ureaplasma spp; ANTIMICROBIAL AGENTS; CHLAMYDIA-TRACHOMATIS; RESISTANT-BACTERIA; MYCOPLASMA-HOMINIS; UREALYTICUM; SUSCEPTIBILITIES; PREVALENCE; PNEUMONIAE; MACROLIDES;
D O I
10.1159/000323629
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: It was the aim of our study to evaluate the in vitro activities of tetracycline (TET), erythromycin (ERY) and levofloxacin (LVX) alone and in dual combinations against ureaplasmas. Methods: The minimum inhibitory concentrations (MICs) of 51 ureaplasmal strains were determined by microdilution assay. Results: TET was the most active when the antibiotics were used alone. The combinations resulted in significantly decreased MICs for every agent compared with the use of single antibiotics (p < 0.05, respectively), except for ERY in the ERY-LVX pair (p > 0.05), and decreased the MICs more significantly in the strains with an MIC >= 4 mg/l compared with MIC <4 mg/l, except for the TET-ERY pair. The ERY-LVX pair increased ERY MICs significantly in the MIC <4 mg/l group (p < 0.05). The combinations resulted in more beneficial MICs in strains where both agents had an MIC >= 4 mg/l compared with those where either had an MIC >= 4 mg/l, as well as in strains where either agent had an MIC <4 mg/l compared with those where both had an MIC <4 mg/l. Conclusions: Drugs in dual combinations always give more beneficial MICs against ureaplasmas than one agent alone. Combinational benefits prefer strains with a higher initial MIC. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:128 / 133
页数:6
相关论文
共 25 条
[11]   Antibacterial resistance worldwide: causes, challenges and responses [J].
Levy, SB ;
Marshall, B .
NATURE MEDICINE, 2004, 10 (12) :S122-S129
[12]   The population dynamics of antimicrobial chemotherapy [J].
Lipsitch, M ;
Levin, BR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) :363-373
[13]  
[罗迪青 LUO Diqing], 2007, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V17, P1048
[14]  
LUO DQ, 2007, CHIN J AIDS STD, V13, P42
[15]  
LUO DQ, 2006, CHIN J DERM VENEREOL, V20, P224
[16]   Transition mutations in 23S rRNA account for acquired resistance to Macrolides in Ureaplasma urealyticum [J].
Meng Dongya ;
Xue Wencheng ;
Ma Xiaobo ;
Wang Lu .
MICROBIAL DRUG RESISTANCE, 2008, 14 (03) :183-186
[17]   Post-Antibiotic Effect of Levofloxacin and Tobramycin Alone or in Combination with Cefepime against Pseudomonas aeruginosa [J].
Ozbek, Berna ;
Otuk, Gulten .
CHEMOTHERAPY, 2009, 55 (06) :446-450
[18]   Ridit analysis on ordinal data [J].
Sermeus, W ;
Delesie, L .
WESTERN JOURNAL OF NURSING RESEARCH, 1996, 18 (03) :351-359
[19]   In vitro effects of spectinomycin and ceftriaxone alone or in combination with other antibiotics against Chlamydia trachomatis [J].
Shang, SX ;
Xia, LQ ;
Zhong, MY ;
Zhang, JP ;
Zhao, JB ;
Gong, XD ;
Mabey, D ;
Wang, QQ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) :1584-1586
[20]  
SU MJ, 2010, GUIDE CHINA MED, V8, P110